US Stock MarketDetailed Quotes

KTTA Pasithea Therapeutics

Watchlist
  • 2.7500
  • -0.1900-6.46%
Close Dec 11 16:00 ET
  • 2.9700
  • +0.2200+8.00%
Post 20:01 ET
3.48MMarket Cap-0.19P/E (TTM)

About Pasithea Therapeutics Company

Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.

Company Profile

SymbolKTTA
Company NamePasithea Therapeutics
Listing DateSep 15, 2021
Issue Price4.99
Founded2020
CEODr. Tiago Reis Marques
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address1111 Lincoln Road,Suite 500
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33139
Phone1-702-514-4174

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Tiago Reis Marques
  • Chief Executive Officer and Director
  • 539.50K
  • Daniel Schneiderman
  • Chief Financial Officer and Principal Accounting Officer
  • 367.20K
  • Dr. Graeme Martin Currie, PhD
  • Chief Development Officer
  • --
  • Dr. Lawrence J. Steinman, M.D.
  • Executive Chairman of the Board
  • 250.00K
  • Alfred J Novak
  • Independent Director
  • 63.59K
  • Dr. Emer Leahy
  • Independent Director
  • 60.00K
  • Simon Dumesnil
  • Independent Director
  • 60.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.